Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan

Journal of Controlled Release

Volumn 66, Issue 2-3, 2000, Pages 281-292

  Lim, S T ^a   Martin, G P ^a   Berry, D J ^b   Brown, M B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Chitosan; Hyaluronic acid; In vitro release profile; Microsphere; Mucociliary transport rate

Indexed keywords

CHITOSAN; CHITOSAN GLUTAMATE; GELATIN; GENTAMICIN; GUM ARABIC; HYALURONIC ACID; KZ 60254; MICROSPHERE; PROTASAN G210; SOLVENT; TISSUE ADHESIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COACERVATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; EVAPORATION; FLUORESCENCE POLARIZATION IMMUNOASSAY; FROG; MICROCAPSULE; MICROPARTICLE; MODEL; MUCOCILIARY TRANSPORT; NONHUMAN; PALATE; PARTICLE SIZE; PRIORITY JOURNAL;

ACACIA; CHITIN; CHITOSAN; DRUG DELIVERY SYSTEMS; FLUORESCENCE POLARIZATION; GELATIN; GENTAMICINS; HYALURONIC ACID; MICROSPHERES; MODELS, THEORETICAL; MUCOUS MEMBRANE;

EID: 0034658305     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00285-0     Document Type: Article

References (50)

1. Nagai T., Machida Y. Mucosal adhesive dosage forms. Pharm. Int. 6:1985;196-199.
2. Helliwell M. The use of bioadhesives in targeted delivery within the gastrointestinal tract. Adv. Drug. Del. Rev. 11:1993;221-251.
3. Gu J.M., Robinson J.R., Leung S.H.S. Binding of acrylic polymers to mucin/epithelial surfaces: structure-property relationships. Crit. Rev. Ther. Drug Carrier Syst. 5:1988;21-67.
4. Middleton D.L., Leung S.H.S., Robinson J.R. Ocular bioadhesive delivery systems. Lenaerts V., Gurny R. Bioadhesive Drug Delivery Systems. 1990;179-202 CRC Press, Boca Raton, FL.
5. Illum L., Joergensen H., Bisgaad H., Krogsgaad O., Rossig N. Bioadhesive microspheres as a potential nasal drug delivery system. Int. J. Pharm. 39:1987;189-194.
6. Nagai T., Konishi R. Buccal/gingival drug delivery systems. J. Control. Release. 6:1987;353-360.
7. Helliwell M., Sektere M.A.O. The formulation of bioadhesive suppositories. Urtti A. Methods To Overcome Biological Barriers in Drug Delivery. 1993;79 Kuopio University Publications. (Pharmaceutical Sciences 10).
8. Richardson J.L., Ramirez P.A., Bendetti L.M., Pastorello A., Callegaro L. Polymeric delivery systems for vaginal drug administration. Proc. Int. Symp. Control. Release Bioact. Mater. 19:1992;308-309.
9. Leung S.S., Robinson J.R. The contribution of anionic polymers structural features to mucoadhesion. J. Control. Release. 5:1988;223-231.
10. Smart J.D. An in vitro assessment of some mucosa-adhesive dosage forms. Int. J. Pharm. 73:1991;69-74.
11. Khoshla R., Davis S.S. The effect of polycarbophil on the gastric emptying of pellets. J. Pharm. Pharmacol. 39:1987;47-49.
12. Parfitt K. Martindale: The Extra Pharmacopoeia. 31st Edition :1996;1754 The Pharmaceutical Press, London.
13. Griffiths M.C. USAN and the USP Dictionary of Drug Names. 1988;277 United States Pharmacopeial Convention.
14. Bottenberg P., Cleymaet R., de Muynck C., Remon J.P., Coomans D., Michotte Y., Slop D. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J. Pharm. Pharmacol. 43:1991;457-464.
15. Rastrelli A., Beccaro M., Biviano F., Calderini G., Pastorello A. Hyaluronic acid esters, a new class of semisynthetic biopolymers: chemical and physico-chemical properties. Heimke G., Soltesz U., Lee A.J.C. Clinical Implant Materials. 1990;199-200 Elsevier, Amsterdam.
16. Benedetti L.M. New biomaterials from hyaluronic acid. Med. Device Technol. 5:(9):1994;32-37.
17. Kyyronen K., Hume L., Benedetti L.M., Urtti A., Topp E., Stella V.J. Methyleprednisolone esters of hyaluronic acid in ophthalmic drug delivery: in vitro and in vivo release studies. Int. J. Pharm. 80:1992;161-169.
18. Benedetti L.M., Topp E.M., Stella V.J. Microspheres of hyaluronic acid esters-fabrication methods and in vitro hydrocortisone release. J. Control. Release. 13:1990;33-41.
19. Pritchard K., Lansley A.B., Martin G.P., Helliwell M., Marriott C., Benedetti L.M. Evaluation of the bioadhesive properties of hyaluronan derivatives: detachment weight and mucociliary transport rate studies. Int. J. Pharm. 129:1996;137-145.
20. Knapczyk J., Krowczynski L., Krzek J., Brzeski M., Nurnberg E., Schnek O., Struszcyk H. Requirements of chitosan for pharmaceutical and biomedical applications. Skak-Braek G., Anthonsen T., Sandford P. Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications. 1989;657-663 Elsevier, London.
21. Hirano S., Seino H., Akiyama I., Nonaka I. Chitosan: a bio-compatible material for oral and intravenous administration. Geblein C.G., Dunn R.L. Progress in Biomedical Polymers. 1990;283-289 Plenum, New York.
22. Tokuyasu K. Utilisation of chitin and chitosan in food industry. J. Jpn. Soc. Food Sci. Technol. (Nippon Shokuhin Kagaku Kogaku Kaishi). 46:1999;356-360.
23. Sezer A.D., Akbuga J. Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads. J. Microencapsulation. 16:1999;195-203.
24. He P., Davis S.S., Illum L. Sustained release chitosan microspheres prepared by novel spray drying methods. J. Microencapsulation. 16:1999;343-355.
25. Jameela S.R., Misra A., Jayakrishnan A. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J. Biomater. Sci. Polymer. 6:1994;621-632.
26. Alaxakis T., Boadi D.K., Quong D., Groboillot A., O'Neill I., Poncelet D., Neufeld R.J. Microencapsulation of DNA within alginate microspheres for in vivo application. Appl. Biochem. Biotech. 50:1995;93-106.
27. Ohya Y., Takei T., Kobayashi H., Ouchi T. Release behaviour of 5-fluorouracil from chitosan-gel micropsheres immobilising 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. J. Microencapsulation. 10:1993;1-9.
28. Hassan E.E., Parish R.C., Gallo J.M. Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. Pharm. Res. 9:1992;390-397.
29. Kas H.S. Chitosan: properties, preparations and applications to microparticulate systems. J. Microencapsulation. 14:1997;689-711.
30. Borchard G., Lueben H.L., de Boer A.G., Verhoef J.C., Lehr C.M., Juginger H.E. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro. J. Control. Release. 39:1996;131-138.
31. Mooren F.C.H., Berthold A., Domschke W., Kreuter J. Influence of chitosan microspheres on the transport of prednisolone sodium phosphate across HT-29 cell monolayers. Pharm. Res. 15:1998;58-65.
32. Calvo P., Remunan-Lopez C., Vila-Jato J.L., Alonso M.J. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 14:1997;1431-1436.
33. Shioya T., Rha C.K. Transmembrane permeability of chitosan/carboxymethylcellulose capsule. Skjak-Braek G., Anthonsen T., Sandford P. Chitin and Chitosan. 1989;627-634 Elsevier, London.
34. Dumitriu S., Chornet E. Inclusion and release of proteins from polysaccharide-based polyion complexes. Adv. Drug. Del. Rev. 31:1998;223-246.
35. Wang J.Q., Bu G.X. An experimental study on nasal absorption of gentamicin in dogs. Chin. Med. J. 107:1994;219-221.
36. Illum L., Farraj N., Critchley H., Davis S.S. Nasal administration of gentamicin using a novel microsphere delivery system. Int. J. Pharm. 46:1988;261-265.
37. Abd El-Hameed and M.D., Kellaway I.W. Preparation and in vitro characterisation of mucoadhesive polymeric microspheres as intra-nasal delivery systems. Eur. J. Pharm. Biopharm. 44:1997;53-60.
38. Burgess D.J., Carless J.E. Manufacture of gelatin/gelatin coacervate microcapsules. Int. J. Pharm. 27:1985;61-70.
39. Burgess D.J., Kwok K.K., Megremis P.T. Characterisation of abumin-acacia complex coacervation. J. Pharm. Pharamacol. 43:1991;232-236.
40. D.S. Reeves, L.O. White, A. Davis, C. McMullin, The UK NEQAS for antibiotic assays report, September 1994 to March 1995. UK NEQAS, Bristol.
41. Shaffar M.R., Stroupe S.D. A general method for performing routine clinical chemistry on the Abbott TDx analyser. Clin. Chem. 129:1983;1251. (Abstract).
42. Dandliker S.B., Kelly R.J., Dandliker J. Fluorescence polarisation immunoassay. Theory and experimental method. Immunochemistry. 10:1973;219-227.
43. Rosenkrantz B.E., Greco J.R., Hoogerheide J.G., Oden E.M. Gentamicin sulphate. Analytical Profiles of Drug Substances. Vol. 9:1980;295-337 Academic Press, New York.
44. Chien Y.W., Su K., Chang S.F. Nasal Systemic Drug Delivery. 1989;Marcel Dekker, New York.
45. Banakar U.V. Pharmaceutical Dissolution Testing. 1992;Marcel Dekker, New York.
46. Deasy P.B. Swarbrick K. Microencapsulation and Related Drug Processes. 1984;Marcel Dekker, New York.
47. Takayama K., Hirata M., Machida Y., Masada T., Sannan T., Nagai T. Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. Chem. Pharm. Bull. 38:1990;1993-1997.
48. Y.Y. Yap, Ph.D. Thesis, King's College London, UK, 1996.
49. Leung H.S., Robinson J.R. Polymer structure features contributing to mucoadhesion II. J. Control. Release. 12:1990;187-194.
50. Borchard G., Lueßen H.L., de Boer A.G., Verhoef J.C., Lehr C.-M., Junginger H.E. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro. J. Control. Release. 39:1996;131-138.